Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Notice of NCLT Convened Meeting of Members and Creditors
May 24, 2025
Prior intimation of Board Meeting_May, 2025
May 20, 2025
Monitoring Agency Report_Q4_March 31, 2025
May 15, 2025
STX_intimation of revised NCLT order
May 13, 2025
Intimation under Reg.30_Allecra
May 10, 2025
STX_intimation of NCLT Order
May 3, 2025
Integrated Governance Report_March 31, 2025
April 29, 2025
Reconciliation of Share Capital_March 31, 2025
April 26, 2025
Certificate under Reg 74(5) of DP Regulation_March 31, 2025
April 11, 2025
Intimation under Reg.30- Joint Memo with DBS
April 9, 2025
Caution Letter_Road Show intimation_June,2024
March 29, 2025
Trading Window Closure_March, 2025
March 27, 2025
Intimation under Reg.30_NCLT Interim Order
March 11, 2025
Intimation of Reveiw of Credit Rating_7th March 2025
March 8, 2025
Intimation under Reg 30_GST Order_Feb 2025
February 28, 2025
Press Release_19.02.2025
February 19, 2025
Previous
1
...
Next
4 / 36